RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R10065 | Losartan potassium | Losartan is an angiotensin II receptor antagonist, competes with the binding of |
| R10066 | Dapagliflozin; BMS512148 | Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM, ex |
| R10068 | GSK1120212; Trametinib; JTP74057 | Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC |
| R10071 | SRT1720 HCl | SRT1720 is a selective SIRT1 activator with EC50 of 0.16 μM in a cell-free assay |
| R10072 | GSK690693 | GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM |
| R10073 | Apitolisib (Synonyms: GDC-0980; GNE 390; RG 7422) | Apitolisib (GDC-0980, RG7422) is a potent, class I PI3K inhibitor for PI3Kα/β/δ/ |
| R10074 | AZ628 | AZ628 is a new pan-Raf inhibitor for BRAF, BRAFV600E, and c-Raf-1 with IC50 of 1 |
| R10075 | Apalutamide (ARN-509) | ARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of |
| R10076 | Crizotinib (PF-02341066) | Crizotinib (PF-02341066) is a potent inhibitor of c-Met and ALK with IC50 of 11 |
| R10077 | AMG208 | AMG 208 is a highly selective c-Met inhibitor with IC50 of 9 nM. Phase 1. |
| R10078 | EMD1214063 | Tepotinib (EMD 1214063) is a potent and selective c-Met inhibitor with IC50 of 4 |
| R10079 | GSK2636771 | GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitiv |
| R10080 | TH-302 | TH-302 is selective hypoxia-activated prodrug targeting hypoxic regions of solid |
| R10081 | TAS103 dihydrochloride | TAS-103 2Hcl(BMS-247615 2Hcl) is a dual inhibitor of topoisomerase-I (topo-I) an |
| R10082 | Palomid 529; P529 | Palomid 529 (P529) inhibits both the mTORC1 and mTORC2 complexes, reduces phosph |
| R10083 | XL413 Hydrochloride | XL413 (BMS-863233) is a potent and selective cell division cycle 7 homolog (CDC7 |
| R10084 | Orteronel; TAK-700 | Orteronel(TAK-700) was selected as a candidate for clinical evaluation. orterone |
| R10085 | KU-55933 | KU-55933 (ATM Kinase Inhibitor) is a potent and specific ATM inhibitor with IC50 |
| R10086 | BAY571293 | Pritelivir (BAY 57-1293) is a potent helicase primase inhibitor, exhibiting anti |
| R10087 | AZD9291 | Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi |
| R10088 | RTA408; Omaveloxolone | Omaveloxolone (RTA-408) is a synthetic triterpenoid that activates the cytoprote |
| R10090 | AZD5438 | AZD5438 is a potent inhibitor of CDK1/2/9 with IC50 of 16 nM/6 nM/20 nM in cell- |
| R10091 | LCZ696;Sacubitril;Valsartan | Varespladib (LY315920) is a potent and selective human non-pancreatic secretory |
| R10092 | TWS11 | TWS119 is a GSK-3β inhibitor with IC50 of 30 nM in a cell-free assay; capable of |
| R10093 | VU0364439 | VU 0364439 is a mGlu4 positive allosteric modulator (PAM), with EC50 of 19.8 nM. |
